AU2002236683A1 - Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates - Google Patents
Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonatesInfo
- Publication number
- AU2002236683A1 AU2002236683A1 AU2002236683A AU3668302A AU2002236683A1 AU 2002236683 A1 AU2002236683 A1 AU 2002236683A1 AU 2002236683 A AU2002236683 A AU 2002236683A AU 3668302 A AU3668302 A AU 3668302A AU 2002236683 A1 AU2002236683 A1 AU 2002236683A1
- Authority
- AU
- Australia
- Prior art keywords
- bisphosphonates
- vivo
- modified
- osteoblastic activity
- isotopic detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940122361 Bisphosphonate Drugs 0.000 title 1
- 150000004663 bisphosphonates Chemical class 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 238000001727 in vivo Methods 0.000 title 1
- 230000001582 osteoblastic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24402000P | 2000-10-27 | 2000-10-27 | |
US60/244,020 | 2000-10-27 | ||
PCT/US2001/051312 WO2002038190A2 (en) | 2000-10-27 | 2001-10-29 | Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002236683A1 true AU2002236683A1 (en) | 2002-05-21 |
Family
ID=22921068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002236683A Abandoned AU2002236683A1 (en) | 2000-10-27 | 2001-10-29 | Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates |
Country Status (4)
Country | Link |
---|---|
US (5) | US6869593B2 (en) |
EP (1) | EP1341557A2 (en) |
AU (1) | AU2002236683A1 (en) |
WO (1) | WO2002038190A2 (en) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002236683A1 (en) * | 2000-10-27 | 2002-05-21 | Beth Israel Deaconess Medical Center | Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates |
EP1221465A1 (en) | 2001-01-03 | 2002-07-10 | Innosense S.r.l. | Symmetric, monofunctionalised polymethine dyes labelling reagents |
DE60214134T2 (en) * | 2001-02-07 | 2007-07-19 | Beth Israel Deaconess Medical Center, Boston | MODIFIED PSMA LIGANDS AND THEIR USE |
US20040073120A1 (en) * | 2002-04-05 | 2004-04-15 | Massachusetts Institute Of Technology | Systems and methods for spectroscopy of biological tissue |
AU2003282810A1 (en) * | 2002-10-10 | 2004-05-04 | Visualsonics Inc. | Integrated multi-rail imaging system |
US8078256B2 (en) * | 2002-10-10 | 2011-12-13 | Visualsonics Inc. | Integrated multi-rail imaging system |
BR0318028A (en) * | 2003-01-24 | 2005-12-06 | Schering Ag | Thiol-reactive cyanine hydrophilic dyes and conjugates thereof with biomolecules for fluorescence diagnosis |
GB0311406D0 (en) | 2003-05-17 | 2003-06-25 | Queen Mary & Westfield College | Substituted phosphonate fluorescent sensors,and use thereof |
JP2005118545A (en) * | 2003-08-18 | 2005-05-12 | Medtronic Vascular Inc | Method for manufacturing dilatation balloon having high elasticity and high strength made of multiblock copolymer |
US20110197556A1 (en) | 2004-11-02 | 2011-08-18 | Baldwin Filters, Inc. | Filter element |
CN1693415B (en) * | 2005-04-29 | 2011-04-13 | 同济大学 | Hydroxy phosphorite of near infrared fluorescence quantum point mark and its preparation process and application |
WO2006121920A2 (en) * | 2005-05-05 | 2006-11-16 | Beth Israel Deaconess Medical Center, Inc. | Micro-scale resonant devices and methods of use |
DK1934211T3 (en) * | 2005-09-02 | 2017-04-10 | Visen Medical Inc | Biocompatible N, N-disubstituted sulfonamide-containing fluorescent color markers |
ES2612738T3 (en) * | 2005-09-02 | 2017-05-18 | Visen Medical, Inc. | Biocompatible fluorescent imaging agents |
EP1934202B1 (en) | 2005-09-02 | 2019-01-09 | Visen Medical, Inc. | Nicotinic acid and picolinic acid derived near-infrared fluorophores |
US9913917B2 (en) | 2005-12-22 | 2018-03-13 | Visen Medical, Inc. | Biocompatible fluorescent metal oxide nanoparticles |
US7865226B2 (en) * | 2006-02-03 | 2011-01-04 | Chiodo Chris D | Specimen positioning system for imaging machines |
DE102006030382A1 (en) * | 2006-06-29 | 2008-01-03 | Carl Zeiss Meditec Ag | Method and device for optical detection on the eye |
CA2692923A1 (en) * | 2006-07-03 | 2008-06-26 | Beth Israel Deaconess Medical Center, Inc. | Intraoperative imaging methods |
EP2044090B1 (en) | 2006-07-10 | 2015-04-08 | The Regents of The University of California | Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides |
WO2008008917A2 (en) * | 2006-07-12 | 2008-01-17 | Mayo Foundation For Medical Education And Research | Hydroxyapatite particles |
WO2008017079A2 (en) * | 2006-08-03 | 2008-02-07 | Beth Israel Deaconess Medical Center, Inc. | Dyes and precursors and conjugates thereof |
US8155730B2 (en) * | 2006-10-24 | 2012-04-10 | The Research Foundation Of State University Of New York | Composition, method, system, and kit for optical electrophysiology |
EP2118206B9 (en) | 2007-02-09 | 2018-08-29 | Visen Medical, Inc. | Polycyclo dyes and use thereof |
WO2008109832A2 (en) * | 2007-03-08 | 2008-09-12 | Visen Medical, Inc. | Viable near-infrared fluorochrome labeled cells and methods of making and using same |
GB0708507D0 (en) | 2007-05-02 | 2007-06-13 | Queen Mary & Westfield College | Substituted phosphonates and their use |
US20110262354A1 (en) | 2007-07-13 | 2011-10-27 | Emory University | Cyanine-containing compounds for cancer imaging and treatment |
WO2009092062A2 (en) * | 2008-01-18 | 2009-07-23 | Visen Medical, Inc. | Fluorescent imaging agents |
CN105288645A (en) * | 2008-06-13 | 2016-02-03 | 西塞医疗中心 | Small molecule ligand-drug conjugates for targeted cancer therapy |
US20100092389A1 (en) * | 2008-10-10 | 2010-04-15 | The General Hospital Corporation | Detection of atherosclerosis using indocyanine green |
WO2011025790A1 (en) | 2009-08-24 | 2011-03-03 | Lumiphore, Inc. | Macrocyclic hopo chelators |
EP2516407A4 (en) * | 2009-12-24 | 2013-06-12 | Lumiphore Inc | Radiopharmaceutical complexes |
US8623324B2 (en) * | 2010-07-21 | 2014-01-07 | Aat Bioquest Inc. | Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates |
US20120059310A1 (en) * | 2010-09-07 | 2012-03-08 | Rao Papineni | Vibration induced in vivo substance targeting |
IT1403567B1 (en) | 2011-01-21 | 2013-10-31 | Univ Palermo | POLYMERIC VECTORS OF POLYASPARTAMID CONJUGATED TO BISPHOSPHONATES FOR THE DIRECTION OF DRUGS TO BONES. |
WO2012154885A2 (en) | 2011-05-09 | 2012-11-15 | Visen Medical, Inc. | Carbonic anhydrase targeting agents and methods of using same |
CN104245954A (en) | 2012-03-30 | 2014-12-24 | 文森医学公司 | Bacterial imaging agents and methods of using same |
AU2013303233C1 (en) | 2012-08-15 | 2018-08-23 | Visen Medical, Inc. | Prostate specific antigen agents and methods of using same for prostate cancer imaging |
GB201306627D0 (en) * | 2013-04-11 | 2013-05-29 | Thompson Richard | Marker |
US11453652B2 (en) | 2013-03-15 | 2022-09-27 | Lumiphore, Inc. | Di-macrocycles |
CN105339436B (en) | 2013-03-15 | 2018-05-25 | 文森医学公司 | Bis- substituted cyclohexyl bridging heptamethine cyanines of 4,4- and its application |
AU2014228504C1 (en) | 2013-03-15 | 2019-10-03 | Visen Medical, Inc. | Substituted silaxanthenium red to near-infrared fluorochromes for in vitro and in vivo imaging and detection |
WO2014153661A1 (en) * | 2013-03-26 | 2014-10-02 | London Health Sciences Centre Research Inc. | Method for detecting and monitoring bone loss |
JP7023604B2 (en) * | 2013-10-31 | 2022-02-22 | ベス・イスラエル・ディーコネス・メディカル・センター,インコーポレイテッド | Near-infrared fluorescence contrast bioimaging agent and its usage |
US11001562B2 (en) | 2013-10-31 | 2021-05-11 | Beth Israel Deaconess Medical Center | Near-infrared fluorescent nerve contrast agents and methods of use thereof |
WO2017053486A1 (en) * | 2015-09-21 | 2017-03-30 | University Of Southern California | Bone active nitrogen-containing bisphosphonates with a near infrared fluorescent label |
GB2569058B (en) * | 2016-01-12 | 2021-04-14 | Cedars Sinai Medical Center | A method of osteogenic differentiation in microfluidic tissue culture systems |
EP3411472A4 (en) | 2016-02-01 | 2020-01-22 | Cedars-Sinai Medical Center | Systems and methods for growth of intestinal cells in microfluidic devices |
US10682597B2 (en) | 2016-04-14 | 2020-06-16 | Baldwin Filters, Inc. | Filter system |
US11253614B2 (en) | 2016-08-23 | 2022-02-22 | University Of Maryland, Baltimore | Methods for detecting and/or predicting age-related macular degeneration and/or Alzheimer's disease |
WO2018140647A1 (en) | 2017-01-25 | 2018-08-02 | Cedars-Sinai Medical Center | In vitro induction of mammary-like differentiation from human pluripotent stem cells |
US11767513B2 (en) | 2017-03-14 | 2023-09-26 | Cedars-Sinai Medical Center | Neuromuscular junction |
WO2018176001A2 (en) | 2017-03-24 | 2018-09-27 | Cedars-Sinai Medical Center | Methods and compositions for production of fallopian tube epithelium |
US10852236B2 (en) * | 2017-09-12 | 2020-12-01 | Curadel, LLC | Method of measuring plant nutrient transport using near-infrared imaging |
CN108344738B (en) * | 2018-01-22 | 2021-07-27 | 翰飞骏德(北京)医疗科技有限公司 | Imaging method for hydroxyapatite and device thereof |
US10952616B2 (en) | 2018-03-30 | 2021-03-23 | Canon U.S.A., Inc. | Fluorescence imaging apparatus |
US10743749B2 (en) | 2018-09-14 | 2020-08-18 | Canon U.S.A., Inc. | System and method for detecting optical probe connection |
US20230110824A1 (en) * | 2020-02-28 | 2023-04-13 | Technische Universität Berlin | Fluorescent probes for detection of calcifications |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5453505A (en) | 1994-06-30 | 1995-09-26 | Biometric Imaging, Inc. | N-heteroaromatic ion and iminium ion substituted cyanine dyes for use as fluorescence labels |
DE4445065A1 (en) | 1994-12-07 | 1996-06-13 | Diagnostikforschung Inst | Methods for in-vivo diagnostics using NIR radiation |
DE19649971A1 (en) | 1996-11-19 | 1998-05-28 | Diagnostikforschung Inst | Optical diagnostics for the diagnosis of neurodegenerative diseases using near-infrared radiation (NIR radiation) |
US6027709A (en) * | 1997-01-10 | 2000-02-22 | Li-Cor Inc. | Fluorescent cyanine dyes |
ATE257014T1 (en) | 1997-04-29 | 2004-01-15 | Amersham Health As | LIGHT IMAGING CONTRAST AGENTS |
AU7221698A (en) | 1997-04-29 | 1998-11-24 | Nycomed Imaging As | Light imaging contrast agents |
US6214812B1 (en) * | 1998-04-02 | 2001-04-10 | Mbc Research, Inc. | Bisphosphonate conjugates and methods of making and using the same |
JP2000095758A (en) * | 1998-09-18 | 2000-04-04 | Schering Ag | Near-infrared, fluorescent contrast medium, and its production |
AU2002236683A1 (en) * | 2000-10-27 | 2002-05-21 | Beth Israel Deaconess Medical Center | Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates |
EP2118206B9 (en) * | 2007-02-09 | 2018-08-29 | Visen Medical, Inc. | Polycyclo dyes and use thereof |
US8431714B2 (en) * | 2007-04-16 | 2013-04-30 | University Of Southern California | Synthesis of drug conjugates via reaction with epoxide-containing linkers |
-
2001
- 2001-10-29 AU AU2002236683A patent/AU2002236683A1/en not_active Abandoned
- 2001-10-29 WO PCT/US2001/051312 patent/WO2002038190A2/en active Application Filing
- 2001-10-29 EP EP01986230A patent/EP1341557A2/en not_active Ceased
-
2003
- 2003-04-25 US US10/424,572 patent/US6869593B2/en not_active Expired - Lifetime
-
2004
- 2004-11-02 US US10/979,786 patent/US20060002857A1/en not_active Abandoned
-
2006
- 2006-08-03 US US11/498,944 patent/US7374746B2/en not_active Expired - Lifetime
-
2008
- 2008-04-17 US US12/104,724 patent/US20090123383A1/en not_active Abandoned
-
2011
- 2011-06-27 US US13/169,500 patent/US20110256065A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20060002857A1 (en) | 2006-01-05 |
US20110256065A1 (en) | 2011-10-20 |
WO2002038190A3 (en) | 2002-08-29 |
US7374746B2 (en) | 2008-05-20 |
US6869593B2 (en) | 2005-03-22 |
WO2002038190A2 (en) | 2002-05-16 |
EP1341557A2 (en) | 2003-09-10 |
US20090123383A1 (en) | 2009-05-14 |
US20040028611A1 (en) | 2004-02-12 |
US20070036724A1 (en) | 2007-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002236683A1 (en) | Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates | |
IL154031A0 (en) | Substituted sulfonylaminomethylbenzoic acid derivatives and preparation | |
AU2001277754A1 (en) | Proline derivatives and use thereof as drugs | |
AU2001288249A1 (en) | Biosensors and methods for their use | |
IL147924A0 (en) | Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents | |
HUP0300746A3 (en) | Proline derivatives and use thereof as drugs | |
HUP0201633A2 (en) | Alpha-aminosulphonyl-acetohydroxamic acid derivatives with metalloprotease inhibiting effect, preparation and use thereof | |
AU5326100A (en) | Pharmaceutical compositions and methods for use | |
AU2001245316A1 (en) | Naphtalene derivatives and their pharmaceutical use | |
HU0001396D0 (en) | 3-amino-3-arylpropan-1-al derivatives and their use | |
AU2002246655A1 (en) | Compositions and methods for detecting proteolytic activity | |
AU2001292122A1 (en) | Heterocyclic derivatives useful as pharmaceutical agents | |
AU2001247196A1 (en) | Methods and compositions for detection of disease | |
AU2002224471A1 (en) | In vivo stimulation of angiogenic activity | |
TW543376U (en) | Physiological pant | |
AU4129800A (en) | Bis-benzazoles and their use as antineoplastic agents | |
IL149534A0 (en) | Preparation of 3-substituted-4-arylquinolin-2-one derivatives | |
AU2001251004A1 (en) | Detection of viable agents | |
AUPQ015299A0 (en) | Ph probe | |
AU7879600A (en) | Interferometric residual-stress analysis | |
IL147103A0 (en) | Substituted isoquinoline derivatives and their use as anticonvulsants | |
AU2001228784A1 (en) | Inositol derivatives and their pharmaceutical use | |
AU3863900A (en) | Prolyl peptidases and methods of use | |
AU2001259564A1 (en) | Pharmaceutical compositions and methods for use | |
AU5974100A (en) | 6-carboxyphenyldihydropyridazinone derivatives and use thereof |